Abstract:Group A streptococcal pyrogenic exotoxin (SPE) type C was partially purified by differential solubility in ethanol and acetate-buffered saline. Toxin prepared in this way consisted of protein and hyaluronic acid. After removal of hyaluronic acid, the toxin remained pyrogenic, enhanced susceptibility of rabbits to lethal endotoxin shock, was stable when treated with acid, base, or pepsin, but was inactivated by heat. Toxin further purified by thin-layer isoelectric focusing was pyrogenic and enhanced the suscep… Show more
“…As has been shown by N-terminal amino acid sequencing the ETC investigated in this work is identical to that decribed by Schlievert et al [26]. According also to data of Goshorn et al [11], the signal peptide of ETC is cleaved at position 28 after serine.…”
Section: Discussionsupporting
confidence: 87%
“…An adequate purification scheme for erythrogenic toxin type C (ETC) is described in this paper. It enabled us, contrary to other already published procedures according to Schlievert et al [26] and Ozegowski et al [21], to obtain highly purified ETC practically in one step and diminish the influence of dephosphorylating activities.…”
Erythrogenic toxin type C (ETC) from different streptococcal group A strains was successively purified by absorption on phenylsepharose, acidic dialysis of the eluate at 40% saturated ammonium sulphate solution, CM-Sepharose chromatography, finally by immunoaffinity chromatography on monoclonal antibodies. Second, after growing of bacteria in the presence of [32P]orthophosphate to phosphorylate ETC, the ETC was purified with phenylsepharose following immunoaffinity chromatography. The occurrence of phosphoamino acids in the purified ETC was investigated by an immunoassay. No phosphoamino acids could be detected in the ETC molecule. Also after radiolabelling with 32P it was not possible to demonstrate a radioactive signal. The treatment with alkaline phosphatase has no influence on the mitogenicity or position of ETC in isoelectric focusing. The results obtained led to the conclusion that in contrast to the literature, ETC is not a phosphorylated protein.
“…As has been shown by N-terminal amino acid sequencing the ETC investigated in this work is identical to that decribed by Schlievert et al [26]. According also to data of Goshorn et al [11], the signal peptide of ETC is cleaved at position 28 after serine.…”
Section: Discussionsupporting
confidence: 87%
“…An adequate purification scheme for erythrogenic toxin type C (ETC) is described in this paper. It enabled us, contrary to other already published procedures according to Schlievert et al [26] and Ozegowski et al [21], to obtain highly purified ETC practically in one step and diminish the influence of dephosphorylating activities.…”
Erythrogenic toxin type C (ETC) from different streptococcal group A strains was successively purified by absorption on phenylsepharose, acidic dialysis of the eluate at 40% saturated ammonium sulphate solution, CM-Sepharose chromatography, finally by immunoaffinity chromatography on monoclonal antibodies. Second, after growing of bacteria in the presence of [32P]orthophosphate to phosphorylate ETC, the ETC was purified with phenylsepharose following immunoaffinity chromatography. The occurrence of phosphoamino acids in the purified ETC was investigated by an immunoassay. No phosphoamino acids could be detected in the ETC molecule. Also after radiolabelling with 32P it was not possible to demonstrate a radioactive signal. The treatment with alkaline phosphatase has no influence on the mitogenicity or position of ETC in isoelectric focusing. The results obtained led to the conclusion that in contrast to the literature, ETC is not a phosphorylated protein.
“…Another group of mitogenic proteins that are produced by group A streptococci are the streptococcal pyrogenic exotoxins (SPE), also known as the streptococcal erythrogenic toxins (7)(8)(9). Three distinct species of SPE exist with mol wt of 8,000, 17,500, and 13,000, respectively, for SPE A, B, and C. The molecular weight and electrophoretic mobility of SPE A and C are clearly different from blastogen A. Exotoxin B, however, is similar in mobility to blastogen A and has an identical molecular weight.…”
An extracellular product of group A streptococci which induces lymphocyte blastogenesis has been purified to homogeneity by DEAE-cellulose and CM-cellulose chromatography. The protein, termed streptococcal blastogen A, has a mol wt of approximately or equal to 17,500 and is inactivated by protease treatment and by heating at 100 degrees C. The purified blastogen gave rise to multiple protein bands on nondenaturing polyacrylamide gel electrophoresis, only two of which possessed blastogenic activity. Treatment of the protein with dithiothreitol before electrophoresis resulted in the apparent conversion of the multiple forms to a single active species. Blastogen A differs in electrophoretic mobility from the streptococcal pyrogenic exotoxins and its lymphocyte stimulating activity is not inhibited by rabbit antisera to the exotoxins. An enzyme immunoassay has been developed to measure human antibodies against blastogen A. A selection of sera with varying levels of anti-DNase B contained antiblastogen A-IgG.
“…Streptococcal pyrogenic exotoxins (SPE) were discovered as the proteins responsible for the rash in scarlet fever (Dick and Dick 1924). Three toxins were later defined which appeared to have superantigenic properties : SPE A (Kim and Watson 1970), SPE B (Barsumian et al 1978) and SPE C (Schlievert et al 1977). Further superantigens have also been identified including SPE D, SPE F, streptococcal superantigen SPE-X and Streptococcus pyogenes mitogen.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.